title: [The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].
abstract: Primary concomitant and sequential chemoradiation is a commonly used therapeutic strategy for head and neck squamous cell carcinoma. At the annual meeting of the 2012 American Society of Clinical Oncology numerous trial results were presented. A selection of the most important trials will be summarized in this article. This year, several important results from phase III trials-including the long awaited comparison of sequential and concomitant chemoradiation-were demonstrated.
authors.affiliation: Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf-Hals-Tumorzentrum des Universitären Cancer Center Hamburg, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland. s.laban@uke.de
authors.forename: S
authors.initials: S
authors.lastname: Laban
authors.forename: V
authors.initials: V
authors.lastname: Zielinski
authors.forename: C-J
authors.initials: CJ
authors.lastname: Busch
authors.forename: A
authors.initials: A
authors.lastname: Münscher
authors.forename: P
authors.initials: P
authors.lastname: Schafhausen
authors.forename: S
authors.initials: S
authors.lastname: Tribius
authors.forename: R
authors.initials: R
authors.lastname: Knecht
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D059248:Chemoradiotherapy / Q000639:trends*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008495:Medical Oncology / Q000639:trends*